Travere Therapeutic | 8-K: Current report
Apr 24 16:11 ET
Travere Therapeutic | DEFA14A: Others
Mar 27 16:38 ET
Travere Therapeutic | DEF 14A: Definitive information statements
Mar 27 16:37 ET
Travere Therapeutic | 8-K: Current report
Feb 23 16:11 ET
Travere Therapeutic | 8-K: Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 15 16:08 ET
Travere Therapeutic | 8-K: Current report
Jan 8 00:00 ET
Travere Therapeutic | 8-K: Current report
Dec 4, 2023 16:10 ET
Travere Therapeutic | 8-K: Travere Therapeutics Reports Third Quarter 2023 Financial Results
Nov 7, 2023 16:04 ET
Travere Therapeutic | 8-K: Current report
Sep 21, 2023 07:35 ET
Travere Therapeutic | 8-K/A: Current report (Amendment)
Sep 7, 2023 17:00 ET
Travere Therapeutic | 8-K: Current report
Sep 5, 2023 08:35 ET
Travere Therapeutic | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 3, 2023 17:11 ET
Travere Therapeutic | 8-K: Travere Therapeutics Reports Second Quarter 2023 Financial Results
Aug 3, 2023 16:06 ET
Travere Therapeutic | 8-K: Current report
Jul 17, 2023 08:07 ET
Travere Therapeutic | 8-K: Current report
May 31, 2023 16:57 ET
Travere Therapeutic | 8-K: Current report
May 22, 2023 16:30 ET
Travere Therapeutic | 8-K: Travere Therapeutics Reports First Quarter 2023 Financial Results
May 4, 2023 16:05 ET
Travere Therapeutic | 8-K: Current report
May 1, 2023 16:07 ET
Travere Therapeutic | DEF 14A: Definitive proxy statements
Apr 13, 2023 17:12 ET
Travere Therapeutic | 8-K: Current report
Apr 12, 2023 16:30 ET
No Data
No Data